T1	Participants 34 76	cervical intraepithelial neoplasia grade 3
T2	Participants 183 293	women diagnosed with rigorously reviewed cervical intraepithelial neoplasia grade 3 (CIN3), cervical precancer
T3	Participants 509 573	women with equivocal (ASCUS) or mildly abnormal (LSIL) Pap tests
T4	Participants 619 628	608 women
T5	Participants 892 921	608 women diagnosed with CIN3
T6	Participants 1862 1904	CIN3 in women with ASCUS and LSIL cytology
